Who invested in GluBio Therapeutics?
GluBio Therapeutics's investors include Qiming Venture Partners, Legend Capital, K2VC, Lilly Asia Ventures and Sanofi.
Who invested in GluBio Therapeutics
One round we have observed, with the 5 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Raised 9 months ago
Funding summaryUpdated 26 Oct 2026
$30Mraised across 1 round since 2026, from 1 source
- Latest round
- Venture, $30MFeb 2026
- Investors
- 5
The rounds
- Feb 2026
Everyone who backed them
Lilly Asia VenturesVC firm1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about GluBio Therapeutics
How much has GluBio Therapeutics raised?
GluBio Therapeutics has raised $30M across 1 round since 2026.
When did GluBio Therapeutics last raise?
GluBio Therapeutics's most recent round was a Venture of $30M in Feb 2026.
What was GluBio Therapeutics's biggest round?
Its most recent round, $30M in Feb 2026, is also its largest on record.
Who backed GluBio Therapeutics first?
GluBio Therapeutics's first round on record, in Feb 2026, was backed by Qiming Venture Partners, Legend Capital and K2VC and 2 others.
What stage is GluBio Therapeutics at?
GluBio Therapeutics's latest named round is a Venture, in Feb 2026.
Companies like GluBio Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.